Evidence map›Paper›PMID 37667186›Full record

ArticleBMC genomic data2023

Gene-based burden scores identify rare variant associations for 28 blood biomarkers.

Rana Aldisi, Emadeldin Hassanin, Sugirthan Sivalingam, Andreas Buness, Hannah Klinkhammer, Andreas Mayr, Holger Fröhlich, Peter Krawitz, Carlo Maj

Abstract read
In one paragraph

Article in BMC genomic data, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rana AldisiInstitute of Genomic Statistic and Bioinformatics, University Hospital Bonn, Bonn, Germany. s0raaldi@uni-bonn.de.
Emadeldin HassaninInstitute of Genomic Statistic and Bioinformatics, University Hospital Bonn, Bonn, Germany.
Sugirthan SivalingamInstitute of Genomic Statistic and Bioinformatics, University Hospital Bonn, Bonn, Germany.
Andreas BunessInstitute of Genomic Statistic and Bioinformatics, University Hospital Bonn, Bonn, Germany.
Hannah KlinkhammerInstitute of Genomic Statistic and Bioinformatics, University Hospital Bonn, Bonn, Germany.
Andreas MayrInstitute of Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Bonn, Germany.
Holger FröhlichFraunhofer Institute for Algorithms and Scientific Computing, Sankt Augustin, Germany.
Peter KrawitzInstitute of Genomic Statistic and Bioinformatics, University Hospital Bonn, Bonn, Germany.
Carlo MajInstitute of Genomic Statistic and Bioinformatics, University Hospital Bonn, Bonn, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA relevant part of the genetic architecture of complex traits is still unknown; despite the discovery of many disease-associated common variants. Polygenic risk score (PRS) models are based on the evaluation of the additive effects attributable to common variants and have been successfully implemented to assess the genetic susceptibility for many phenotypes. In contrast, burden tests are often used to identify an enrichment of rare deleterious variants in specific genes. Both kinds of genetic contributions are typically analyzed independently. Many studies suggest that complex phenotypes are influenced by both low effect common variants and high effect rare deleterious variants. The aim of this paper is to integrate the effect of both common and rare functional variants for a more comprehensive genetic risk modeling.

methodsWe developed a framework combining gene-based scores based on the enrichment of rare functionally relevant variants with genome-wide PRS based on common variants for association analysis and prediction models. We applied our framework on UK Biobank dataset with genotyping and exome data and considered 28 blood biomarkers levels as target phenotypes. For each biomarker, an association analysis was performed on full cohort using gene-based scores (GBS). The cohort was then split into 3 subsets for PRS construction and feature selection, predictive model training, and independent evaluation, respectively. Prediction models were generated including either PRS, GBS or both (combined).

resultsAssociation analyses of the cohort were able to detect significant genes that were previously known to be associated with different biomarkers. Interestingly, the analyses also revealed heterogeneous effect sizes and directionality highlighting the complexity of the blood biomarkers regulation. However, the combined models for many biomarkers show little or no improvement in prediction accuracy compared to the PRS models.

conclusionThis study shows that rare variants play an important role in the genetic architecture of complex multifactorial traits such as blood biomarkers. However, while rare deleterious variants play a strong role at an individual level, our results indicate that classical common variant based PRS might be more informative to predict the genetic susceptibility at the population level.

Indexed as

ExomeGenetic Predisposition to DiseaseBiomarkersHumansMultifactorial InheritancePhenotypeBiomarkersBlood biomarkersComplex phenotypesGene associationsGenetic predictionPRSRare variants

Identifiers

PMID37667186
PMCPMC10476296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.